{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T06:26:56Z","timestamp":1791440816003,"version":"4.3.3"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T00:00:00Z","timestamp":1536796800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0203655","type":"journal-article","created":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T13:39:22Z","timestamp":1536845962000},"page":"e0203655","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":56,"title":["The sodium-glucose co-transporter 2 inhibitor velagliflozin reduces hyperinsulinemia and prevents laminitis in insulin-dysregulated ponies"],"prefix":"10.1371","volume":"13","author":[{"given":"Alexandra","family":"Meier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dania","family":"Reiche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7922-3642","authenticated-orcid":true,"given":"Melody","family":"de Laat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Pollitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2837-5456","authenticated-orcid":true,"given":"Martin","family":"Sillence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,9,13]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.domaniend.2011.05.004","article-title":"The prevalence of endocrinopathic laminitis among horses presented for laminitis at a first-opinion\/referral equine hospital","volume":"41","author":"N Karikoski","year":"2011","journal-title":"Domestic Animal Endocrinology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"E61","DOI":"10.1152\/ajpendo.00362.2015","article-title":"Equine hyperinsulinemia: investigation of the enteroinsular axis during insulin dysregulation","volume":"310","author":"M de Laat","year":"2015","journal-title":"American Journal of Physiology\u2014Endocrinology and Metabolism"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2746\/0425164044877288","article-title":"Serum insulin concentrations in horses with equine Cushing&apos;s syndrome: response to a cortisol inhibitor and prognostic value","volume":"36","author":"C McGowan","year":"2004","journal-title":"Equine Veterinary Journal"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.tvjl.2007.07.003","article-title":"Induction of laminitis by prolonged hyperinsulinaemia in clinically normal ponies","volume":"174","author":"K Asplin","year":"2007","journal-title":"The Veterinary Journal"},{"key":"ref5","first-page":"742","article-title":"Treatment with pergolide or cyproheptadine of pituitary <italic>pars intermedia<\/italic> dysfunction (equine cushing&apos;s disease)","volume":"16","author":"M Donaldson","year":"2002","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/evj.12169","article-title":"Insulin dysregulation","volume":"46","author":"N Frank","year":"2014","journal-title":"Equine Veterinary Journal"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2042-3306.1992.tb02812.x","article-title":"Improved insulin sensitivity in hyperinsulinaemic ponies through physical conditioning and controlled feed intake","volume":"24","author":"J Freestone","year":"1992","journal-title":"Equine Veterinary Journal"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.2042-3306.2002.tb05396.x","article-title":"Effect of short-term exercise training on insulin sensitivity in obese and lean mares","volume":"34","author":"D Powell","year":"2010","journal-title":"Equine Veterinary Journal"},{"key":"ref9","first-page":"371","article-title":"Endocrinopathic laminitis: reducing the risk through diet and exercise","volume":"26","author":"N Menzies-Gow","year":"2010","journal-title":"Veterinary Clinics of North America: Equine Practice"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2337\/diaclin.28.1.5","article-title":"Apple trees to sodium glucose co-transporter inhibitors: a review of SGLT2 inhibition","volume":"28","author":"J White","year":"2010","journal-title":"Clinical Diabetes"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0300-9084(78)80783-4","article-title":"Glucose transport by horse kidney brush borders.\u2014Transport properties of brush border membrane closed vesicles","volume":"60","author":"J Poir\u00e9e","year":"1978","journal-title":"Biochimie"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.domaniend.2017.10.008","article-title":"The oral glucose test predicts laminitis risk in ponies fed a diet high in nonstructural carbohydrates","volume":"63","author":"A Meier","year":"2017","journal-title":"Domestic Animal Endocrinology"},{"key":"ref13","article-title":"Recommendations for the diagnosis and treatment of equine metabolic syndrome (EMS) Equine Endocrinology Group","author":"N Frank","year":"2016"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.2042-3306.1983.tb01826.x","article-title":"Relationship between condition score, physical measurements and body fat percentage in mares","volume":"15","author":"D Henneke","year":"1983","journal-title":"Equine Veterinary Journal"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.tvjl.2008.02.029","article-title":"Apparent adiposity assessed by standardised scoring systems and morphometric measurements in horses and ponies","volume":"179","author":"R Carter","year":"2009","journal-title":"The Veterinary Journal"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.2042-3306.2012.00575.x","article-title":"Evaluation of basal plasma \u03b1-melanocyte-stimulating hormone and adrenocorticotrophic hormone concentrations for the diagnosis of pituitary pars intermedia dysfunction from a population of aged horses","volume":"45","author":"T McGowan","year":"2012","journal-title":"Equine Veterinary Journal"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/evj.12703","article-title":"The diagnosis of insulin dysregulation","volume":"49","author":"F Bertin","year":"2017","journal-title":"Equine Veterinary Journal"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7573\/dic.212262","article-title":"Empagliflozin: a new sodium-glucose co-transporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes","author":"J Neumiller","year":"2014","journal-title":"Drugs in Context"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1038\/ki.2010.512","article-title":"Glucose dynamics and mechanistic implications of SGLT2 inhibitors in animals and humans","volume":"79","author":"J List","year":"2011","journal-title":"Kidney International"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/evj.12450","article-title":"Lamellar pathology in horses with pituitary <italic>pars intermedia<\/italic> dysfunction","volume":"48","author":"N Karikoski","year":"2015","journal-title":"Equine Veterinary Journal"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2746\/0425164044877288","article-title":"Serum insulin concentrations in horses with equine Cushing&apos;s syndrome: response to a cortisol inhibitor and prognostic value","volume":"36","author":"C McGowan","year":"2010","journal-title":"Equine Veterinary Journal"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.2042-3306.2012.00578.x","article-title":"Prevalence, risk factors and clinical signs predictive for equine pituitary <italic>pars intermedia<\/italic> dysfunction in aged horses","volume":"45","author":"T McGowan","year":"2012","journal-title":"Equine Veterinary Journal"},{"key":"ref23","first-page":"334","article-title":"Equine Laminitis","author":"D McFarlane","year":"2017"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1124\/jpet.108.140210","article-title":"Remogliflozin etabonate, in a novel category of selective low-affinity sodium glucose cotransporter (SGLT2) Inhibitors, exhibits antidiabetic efficacy in rodent models","volume":"327","author":"Y Fujimori","year":"2008","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.2460\/javma.228.10.1538","article-title":"Evaluation of genetic and metabolic predispositions and nutritional risk factors for pasture-associated laminitis in ponies","volume":"228","author":"K Treiber","year":"2006","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/jvim.12056","article-title":"Adiposity, plasma insulin, leptin, lipids, and oxidative stress in mature light breed horses","volume":"27","author":"R Pleasant","year":"2013","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/avj.12159","article-title":"Prevalence and risk factors for hyperinsulinaemia in ponies in Queensland, Australia","volume":"92","author":"R Morgan","year":"2014","journal-title":"Australian Veterinary Journal"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.2527\/jas.2006-673","article-title":"Relationships among inflammatory cytokines, obesity, and insulin sensitivity in the horse","volume":"85","author":"M Vick","year":"2007","journal-title":"Journal of Animal Science"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2746\/042516408X342975","article-title":"Prediction of incipient pasture-associated laminitis from hyperinsulinaemia, hyperleptinaemia and generalised and localised obesity in a cohort of ponies","volume":"41","author":"R Carter","year":"2009","journal-title":"Equine Veterinary Journal"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/jvim.12021","article-title":"Relationships between body condition score and plasma inflammatory cytokines, insulin, and lipids in a mixed population of light-breed horses","volume":"27","author":"J Suagee","year":"2012","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"ref31","article-title":"Serum Biochemical Reference Ranges\u2013Appendixes- Veterinary Manual","author":"S Fielder","year":"2018"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.metabol.2014.06.018","article-title":"The role of the kidneys in glucose homeostasis in type 2 diabetes: clinical implications and therapeutic significance through sodium glucose co-transporter 2 inhibitors","volume":"63","author":"J Wilding","year":"2014","journal-title":"Metabolism"},{"key":"ref33","first-page":"1","article-title":"Effects of the sodium-glucose cotransporter 2 (SGLT2) inhibitor velagliflozin, a new drug with therapeutic potential to treat diabetes in cats","author":"M Hoenig","year":"2017","journal-title":"Journal of Veterinary Pharmacology and Therapeutics"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2215\/CJN.04010609","article-title":"Familial renal glucosuria and SGLT2: from a mendelian trait to a therapeutic target","volume":"5","author":"R Santer","year":"2009","journal-title":"Clinical Journal of the American Society of Nephrology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1086\/431587","article-title":"Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus","volume":"41","author":"L Muller","year":"2005","journal-title":"Clinical Infectious Diseases"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/dom.12064","article-title":"Inhibition of the sodium glucose co-transporter-2: its beneficial action and potential combination therapy for type 2 diabetes mellitus","volume":"15","author":"L Chen","year":"2013","journal-title":"Diabetes, Obesity and Metabolism"},{"key":"ref37","first-page":"39","article-title":"Pasture-associated laminitis","volume":"25","author":"R Geor","year":"2009","journal-title":"Veterinary Clinics of North America: Equine Practice"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1177\/0300985814549212","article-title":"Pathology of natural cases of equine endocrinopathic laminitis associated with hyperinsulinemia","volume":"52","author":"N Karikoski","year":"2015","journal-title":"Veterinary Pathology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0203655","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T16:28:49Z","timestamp":1588955329000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0203655"}},"subtitle":[],"editor":[{"given":"Chris","family":"Rogers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,9,13]]},"references-count":38,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,9,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0203655","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,13]]}}}